A hypothetical biological synovial fluid for treatment of temporomandibular joint disease

Medical Hypotheses

Volumn 70, Issue 4, 2008, Pages 835-837

  Meng, Qing Gong ^a   Long, Xing ^a  

^a Wuhan University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; PHOSPHOLIPID DERIVATIVE;

ARTICLE; BIOLOGICAL THERAPY; GEL PERMEATION CHROMATOGRAPHY; HUMAN; LUBRICATION; MESENCHYMAL STEM CELL; OSTEOARTHRITIS; PRIORITY JOURNAL; SENESCENCE; SYNOVIAL FLUID; SYNOVIUM; TEMPOROMANDIBULAR JOINT DISORDER; ULTRAFILTRATION;

ANIMALS; CARTILAGE; CELL AGING; DISEASE MODELS, ANIMAL; HUMANS; HYALURONIC ACID; MESENCHYMAL STEM CELLS; MODELS, BIOLOGICAL; MODELS, THEORETICAL; OSTEOARTHRITIS; PHOSPHOLIPIDS; SYNOVIAL FLUID; TEMPOROMANDIBULAR JOINT DISORDERS;

EID: 40149104832     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.07.033     Document Type: Article

References (22)

1. Michael Miloro. Peterson's principles of oral and maxillofacial surgery. 2nd ed., 2004; p. 875-1476.
2. Thambyah A. A hypothesis matrix for studying biomechanical factors associated with the initiation and progression of posttraumatic osteoarthritis. Med Hypotheses 64 6 (2005) 1157-1161
3. Struglics A., Larsson S., Pratta M.A., et al. Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments. Osteoarth Cartilage 14 2 (2006) 101-113
4. Yoshida K., Takatsuka S., Hatada E., et al. Expression of matrix metalloproteinases and aggrecanase in the synovial fluids of patients with symptomatic temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102 1 (2006) 22-27
5. van den Boom R., van de Lest C.H., Bull S., et al. Influence of repeated arthrocentesis and exercise on synovial fluid concentrations of nitric oxide, prostaglandin E2 and glycosaminoglycans in healthy equine joints. Equine Vet J 37 3 (2005) 250-256
6. Richette P., Laborde K., Boutron C., et al. Correlation between serum and synovial fluid estrogen concentrations: Comment on the article by Sowers et al. Arthritis Rheum 56 2 (2007) 698
7. Jacobsen S., Thomsen M.H., and Nanni S. Concentrations of serum amyloid A in serum and synovial fluid from healthy horses and horses with joint disease. Am J Vet Res 67 10 (2006) 1738-1742
8. Suzuki A., Nozawa-Inoue K., Amizuka N., et al. Localization of CD44 and hyaluronan in the synovial membrane of the rat temporomandibular joint. Anat Rec A Discov Mol Cell Evol Biol 288 6 (2006) 646-652
9. Elsaid K.A., Jay G.D., and Chichester C.O. Reduced expression and proteolytic susceptibility of lubricin/superficial zone protein may explain early elevation in the coefficient of friction in the joints of rats with antigen-induced arthritis. Arthritis Rheum 56 1 (2007) 108-116
10. Schwarz I.M., and Hills B.A. Surface-active phospholipid as the lubricating component of lubricin. Br J Rheumatol 37 1 (1998) 21-26
11. Karatay S., Kiziltunc A., Yildirim K., et al. Effects of different hyaluronic acid products on synovial fluid NO levels in knee osteoarthritis. Clin Rheumatol 24 5 (2005) 497-501
12. Djouad F., Bony C., Haupl T., et al. Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells. Arthritis Res Ther 7 6 (2005) R1304-R1315
13. Jones E.A., English A., Henshaw K., et al. Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis. Arthritis Rheum 50 3 (2004) 817-827
14. Green D.M., Noble P.C., Bocell Jr. J.R., et al. Effect of early full weight-bearing after joint injury on inflammation and cartilage degradation. J Bone Joint Surg Am 88 10 (2006) 2201-2209
15. Nugent G.E., Schmidt T.A., Schumacher B.L., et al. Static and dynamic compression regulate cartilage metabolism of Proteoglycan 4 (PRG4). Biorheology 43 3-4 (2006) 191-200
16. Zappone B., Ruths M., Greene G.W., et al. Adsorption, lubrication and wear of Lubricin on model surfaces: Polymer brush-like behavior of a glycoprotein. Biophys J (2006) Epub ahead of print
17. Wang C.T., Lin Y.T., Chiang B.L., et al. High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis. Osteoarthritis Cartilage 14 12 (2006) 1237-1247
18. Canapp S.O., Cross A.R., Brown M.P., Tran-Son-Tay R., et al. Examination of synovial fluid and serum following intravenous injections of hyaluronan for the treatment of osteoarthritis in dogs. Vet Comp Orthop Traumatol 18 3 (2005) 169-174
19. Dagenais S. Intra-articular hyaluronic acid (viscosupplementation) for knee osteoarthritis. Issues Emerg Health Technol 94 (2006) 1-4
20. Mosca J.D., Moorman M.A., Simonetti D.W., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143D-147D
21. Vadilenkaitis V.V., and Matulis A.A. Artificial synovial fluid for the intra-articular treatment of rheumatoid arthritis and osteoarthritis (chemical synthesis and clinico-experimental and biomechanical data). Ter Arkh 56 11 (1984) 73-77
22. Vasilenkaitis V.V. Artificial synovial fluid for the joints Ortop. Travmatol Protez 10 (1989) 11-15 Oct